Table 1.
Patients’ demographics and clinical data.
| Data | Median (IQR) or Number of Observations (%) |
|---|---|
| Age | 60 (51, 69) |
| Females | 95 (34%) |
| Males | 187 (66%) |
| symptoms onset (days) | 7 (4, 10) |
| %CL admission | 11% (6, 18) |
| %PAL admission | 9% (5, 14) |
| %CL follow-up | 5% (4, 6) |
| %PAL follow-up | 4% (3, 5) |
| %deltaCL | −4% (−11, −1) |
| %deltaPAL | −3% (−9, −1) |
| length of stay | 9 (7, 15) |
| lung disease | 39 (13%) |
| Therapy | |
| corticosteroid | 21 (7%) |
| heparin | 107 (38%) |
| oxygen | 172 (61%) |
| intubation | 15 (5%) |
| Follow-up | |
| thoracalgia | 14 (5%) |
| dyspnea | 6 (2%) |
| coughing | 3 (1%) |
| days between scans | 48 (42, 59) |
| days to negative swab | 33 (25, 43) |
IQR: interquartile range; %CL: compromised lung; %PAL: poorly aerated lung.